Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04922944 · ClinicalTrials.gov registry record
Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients
A clinical trial of Covid19 and Vaccine Reaction, sponsored by Huntington Memorial Hospital.
- Completed
- Registry status
- 167
- Enrollment target
- 1
- Study location
NCT04922944 is a study of Covid19 and Vaccine Reaction that has completed, run by Huntington Memorial Hospital. The registered enrollment target is 167 participants, below the 2,701-participant average among 94 other Covid19 trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04922944, a study of Covid19 and Vaccine Reaction, has completed, sponsored by Huntington Memorial Hospital.
- COMPLETED
- Registry status
- 167 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is studying how healthcare worker recipients react after receiving vaccinations for COVID-19. The objective of the study is to evaluate the immune response to COVID-19 vaccination. The immunity will be evaluated over time by measuring serum semi-quantitative SARS-Co-V2 IgG from blood specimens and analyzing vaccine reaction data. SARS-CoV-2 is the name for the virus responsible for COVID-19 infections. IgG, immunoglobulin G, is an antibody found in the blood that protects against bacterial and viral infections. Study subjects will also be asked to report physical reactions they may have experienced related to vaccinations.
Conditions Studied
Interventions
- DRUG COVID-19 vaccine
Study Locations (1)
California
- Huntington Hospital - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2021-03-08 |
| Est. Completion | 2022-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04922944
The ClinicalTrials.gov registry entry for NCT04922944 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,701-participant average among 94 other Covid19 trials with a reported enrollment target (94% lower). The listed sponsor is Huntington Memorial Hospital, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which COVID-19 vaccine is the first listed.
NCT04922944 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04922944 about?
NCT04922944 is a clinical study titled "Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients". This research study is studying how healthcare worker recipients react after receiving vaccinations for COVID-19. The objective of the study is to evaluate the immune response to COVID-19 vaccination. The immunity will be evaluated over time by measuring serum semi-quantitative SARS-Co-V2 IgG from b...
What is the current status of trial NCT04922944?
This trial is currently completed. The enrollment target is 167 participants. The study started on 2021-03-08. Estimated completion is 2022-03-01.
What conditions does trial NCT04922944 study?
This clinical trial studies the following conditions: Covid19, Vaccine Reaction.
What interventions are being tested in trial NCT04922944?
The interventions under investigation include: COVID-19 vaccine (DRUG).
Who is sponsoring clinical trial NCT04922944?
This trial is sponsored by Huntington Memorial Hospital, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04922944 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.